In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Larimar Therapeutics Inc (NASDAQ: LRMR) closed the day trading at $3.96 up 0.76% from the previous closing price of $3.93. In other words, the price has increased by $0.76 from its previous closing price. On the day, 0.54 million shares were traded. LRMR stock price reached its highest trading level at $4.0 during the session, while it also had its lowest trading level at $3.86.
Ratios:
For a better understanding of LRMR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.06 and its Current Ratio is at 4.06. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In the most recent recommendation for this company, Truist on January 29, 2025, initiated with a Buy rating and assigned the stock a target price of $18.
On October 16, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $26.
On October 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $22.Wedbush initiated its Outperform rating on October 03, 2024, with a $22 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 31 ’25 when Flynn James E bought 9,375,000 shares for $3.20 per share. The transaction valued at 30,000,000 led to the insider holds 9,538,945 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 338937952 and an Enterprise Value of 167849952.
Stock Price History:
The Beta on a monthly basis for LRMR is 1.07, which has changed by 0.015503883 over the last 52 weeks, in comparison to a change of 0.17823458 over the same period for the S&P500. Over the past 52 weeks, LRMR has reached a high of $5.37, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is 5.33%, while the 200-Day Moving Average is calculated to be 21.18%.
Shares Statistics:
Over the past 3-months, LRMR traded about 2.43M shares per day on average, while over the past 10 days, LRMR traded about 1281010 shares per day. A total of 85.59M shares are outstanding, with a floating share count of 47.71M. Insiders hold about 44.26% of the company’s shares, while institutions hold 57.37% stake in the company. Shares short for LRMR as of 1765756800 were 7922334 with a Short Ratio of 3.27, compared to 1763078400 on 10075712. Therefore, it implies a Short% of Shares Outstanding of 7922334 and a Short% of Float of 13.91.
Earnings Estimates
Currently, 7.0 analysts are dedicated to thoroughly evaluating and rating the performance of Larimar Therapeutics Inc (LRMR) in the stock market.The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.41 and low estimates of -$0.51.
Analysts are recommending an EPS of between -$1.7 and -$2.18 for the fiscal current year, implying an average EPS of -$1.99. EPS for the following year is -$1.82, with 7.0 analysts recommending between -$1.39 and -$2.54.
